Similar Articles
311 Present and future of new systemic therapies for early and intermediate stages of hepatocellular carcinoma
312 Cell division cyclin 25C knockdown inhibits hepatocellular carcinoma development by inducing endoplasmic reticulum stress
313 Meta-analysis of new intervention measures for preventing side effects of artificial joint replacement
314 Coexistence of liver abscess, hepatic cystic echinococcosis and hepatocellular carcinoma: A case report
315 Dipeptidyl peptidase-4 inhibitors and the risk of infection: A systematic review and meta-analysis of cardiovascular outcome trials
316 Albumin–bilirubin grade as a predictor of survival in hepatocellular carcinoma patients with thrombocytopenia
317 Perioperative remedial antiviral therapy in hepatitis B virus-related hepatocellular carcinoma resection: How to achieve a better outcome
318 Plexin domain-containing 1 may be a biomarker of poor prognosis in hepatocellular carcinoma patients, may mediate immune evasion
319 Association of complement components with risk of colorectal cancer: A systematic review and meta-analysis
320 Multidisciplinary comprehensive treatment of massive hepatocellular carcinoma with hemorrhage: A case report and review of literature
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA